Inactive Instrument

Avivagen Inc Share Price Toronto S.E.

Equities

VIV

CA05382F1036

Fishing & Farming

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2021 1.3M 952K 79.24M Sales 2022 939K 690K 57.42M Capitalization 10.42M 7.66M 637M
Net income 2021 -6M -4.41M -367M Net income 2022 -6M -4.41M -367M EV / Sales 2021 21.5 x
Net Debt 2021 5.4M 3.97M 330M Net Debt 2022 5.8M 4.26M 354M EV / Sales 2022 17.3 x
P/E ratio 2021
-3.24 x
P/E ratio 2022
-1.47 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 98.89%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Founder - 04/05/04
Chief Executive Officer 68 04/14/04
Director of Finance/CFO - -
Members of the board TitleAgeSince
Chairman 59 01/13/01
Director/Board Member - 22/17/22
Chief Executive Officer 68 04/14/04
More insiders
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW